Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of January 18)
This week's View focuses on the coronavirus disease 2019 (COVID-19) resources on ACC.org, including recently published articles on the difference in sensitivity and cost for severe acute respiratory syndrome coronavirus 2 detection between nasopharyngeal swabs and saliva testing, the effect of discontinuation of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the number of days alive and out of the hospital in patients with COVID-19, and the corrected QT prolongation in a cohort of patients hospitalized with COVID-19 treated with combination hydroxychloroquine and azithromycin.
Clinical Topics: Arrhythmias and Clinical EP, Congenital Heart Disease and Pediatric Cardiology, Heart Failure and Cardiomyopathies, Prevention, Implantable Devices, Genetic Arrhythmic Conditions, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Congenital Heart Disease, CHD and Pediatrics and Arrhythmias, Novel Agents, Statins, Acute Heart Failure
Keywords: EaglesEyeView, COVID-19, ACC COVID-19 Podcast, Coronavirus, Coronavirus Infections, severe acute respiratory syndrome coronavirus 2, Pandemics, Acute Kidney Injury, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Arrhythmias, Cardiac, Azithromycin, Body Mass Index, Chloroquine, Cost-Benefit Analysis, Creatinine, Diagnostic Tests, Routine, Heart Failure, Hydroxychloroquine, Long QT Syndrome, Myocardial Infarction, Nasopharynx, Primary Prevention, Renal Dialysis, Respiration, Artificial, Respiratory Insufficiency, Saliva, Shock, Tachycardia, Ventricular, Troponin, Ventricular Fibrillation, Heart Defects, Congenital
< Back to Listings